Barhemsys 10 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FFEA4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,736
Award facts
- Contract value 100% obligated
- $12,736.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Barhemsys 10 mg/4 ml vials with a ceiling value of $12.7K. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competitively awarded. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1B and extending through December 2026, which serves as the primary vehicle for the company's pharmaceutical and medical supply deliveries to support military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare needs through the DLA Medical Supply Chain. The company maintains an extensive portfolio of federal contract awards for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As the child contract under the larger SPE2DX IDC, this delivery order exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems through flexible and comprehensive contract vehicles designed to meet the military's ongoing pharmaceutical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FFEA4?
SPE2DB25FFEA4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FFEA4 worth?
The government has obligated $12,736 on SPE2DB25FFEA4.
Is contract SPE2DB25FFEA4 an order under another contract?
Yes. SPE2DB25FFEA4 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFEA4 competed?
The extent of competition for SPE2DB25FFEA4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award